ABIM: Self-paced MOC pathway under development
By Alicia Gallegos
The longitudinal assessment option will provide doctors with immediate feedback about answers and links to educational material.
The new drug inclisiran potently cut LDL cholesterol by inhibiting the PCSK9 enzyme.
In sharp contrast with the viral hepatitis findings, mortality rates among patients with ALD and NAFLD have increased.
The state health agency is expected to issue rules outlining the ban within the next 30 days.
Clinicians encounter significant difficulties when addressing needs of unaccompanied immigrant children in federal custody, OIG report finds.